Update on the heritability of inflammatory bowel disease: The importance of twin studies
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Initial reports of familial clustering of inflammatory bowel disease (IBD), i.e., families with multiple relatives with Crohn's disease (CD) or ulcerative colitis (UC), suggested that these relatively uncommon disorders might be due to substantial genetic effects. Case series later showed that IBD risk to relatives of IBD probands (first person with IBD identified in a family) far exceeded that expected for relatively uncommon disorders. For example, in one of the first population-based studies of familial IBD, Orholm et al1 observed that the risk of CD to first-degree relatives of CD patients was 10-fold greater and the risk of UC to relatives of UC patients was 8-fold greater than the risk of CD or UC to first-degree relatives of healthy controls. Additionally, CD and UC appeared genetically related, as CD risk for a relative of a UC case was 2-fold greater and the opposite risk was 4-fold greater than that for individuals without an IBD family history. Nonetheless, detractors to theories of IBD having genetic origins noted that UC and CD incidence rates increased greatly—and steadily—each decade since first ascertained, far greater than could be accounted by greater disease recognition, and incidences differed widely by geography.2 Moreover, familial clustering might be due to environmental factors (e.g., predisposing microorganisms shared among relatives). However, long before the discovery of the now more than 40 established genes for CD and UC,3, 4 IBD case reports in monozygotic twins (MZ) suggested that IBD was unusually heritable, with 17 of 20 CD pairs and 5 of 11 UC pairs concordant for disease.5 The first study of IBD among unselected, population-based twins, the Swedish twin registry, provided the proof that IBD, particularly CD, was in large part due to major genetic risk factors—although the MZ twin concordance, with probands identified by discharge diagnoses in public hospitals and diagnoses confirmed by review of medical records, was far less than that suggested by the case reports in the literature.5 In 1988, Tysk et al5 identified 34 MZ and 43 same-sex dizygotic (DZ) twins with at least one diagnosis of CD or UC. Among the 18 MZ twins with a CD proband, eight were concordant for CD; among the 26 DZ twins with a CD proband, only one was concordant (Table 1). In contrast, the observed MZ and DZ concordance for UC was 6.3% and 0%, respectively. As noted by the authors, the CD heritability of liability estimate of 1.0 (95% confidence interval [CI] 0.80–1.0) was higher and the UC estimate of 0.53 (95% CI 0.24–0.82) similar to concurrent estimates reported for diabetes (0.77), hypertension (0.57), or asthma (0.29). IBD Reported in Published Studies of Unselected Twin Cohorts IBD Reported in Published Studies of Unselected Twin Cohorts The remarkably greater MZ compared to DZ concordance for CD can only be explained by genetic factors: while both twin types are born at the same time and had all been reared in the same environment, MZ twins are essentially human clones of each other, having originated from the same zygote and thus having inherited the identical genetic material from both their mothers and fathers. DZ twin pairs are genetically as related as non-twin sibling pairs and will inherit the identical copy of any given gene from their mother or their father only 50% of the time. Additionally, the incomplete concordance among MZ twins suggested that within the same general environment, specific environmental or other acquired risk factors either trigger CD or UC in the affected twin, or perhaps for some factors, “protect” the unaffected twin. For example, in an investigation that utilized Swedish and Danish IBD twin cohorts, smoking was 5-fold protective of UC among discordant MZ twins.6 The Swedish twin registry findings of 1988 were a major incentive to proceed with molecular genetics research to identify genes for CD (which in turn has been one of the leading complex disorders to have susceptibility genes identified), and might have discouraged research to identify genes for UC. The twin cohorts that followed (Table 1) either supported the high CD concordance for MZ twins or observed a substantially reduced MZ twin concordance rate than the original Swedish twin study, whereas UC was observed to be more genetic.7,–10 Had the landmark, Swedish population-based twin study overestimated heritability of CD and underestimated that of UC, or was CD more genetic in the Scandinavian population as suggested by the Danish study that identified probands by questionnaires with a high rate of return mailed to a large twin registry? If anything, a longitudinal follow-up limited to the original Swedish IBD twins suggested that MZ concordance for both CD and UC was underestimated due to failure to diagnose or identify IBD: a co-twin suspected of having CD in the original study was formally diagnosed in 1992 (26 years after his brother was diagnosed with CD in 1966); a co-twin with insufficient evidenc
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
the NIDDK IBD Genetics Consortium, Barrett, J. C., the Belgian-French IBD Consortium, the Wellcome Trust Case Control Consortium, Hansoul, S., Nicolae, D. L., Cho, J. H., Duerr, R. H., Rioux, J. D., Brant, S. R., et al. (2008) · Nature Genetics · doi:10.1038/ng.175 · Cited by 2,593
Self-citationWilling, B., Halfvarson, J., Dicksved, J., Rosenquist, M., Järnerot, G., Engstrand, L., Tysk, C., & Jansson, J. K. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20783 · Cited by 455
Cited by
Understanding and Preventing the Global Increase of Inflammatory Bowel Disease
Kaplan, G. G., & Ng, S. C. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.10.020 · Cited by 1,224
National Institute of Diabetes and Digestive Kidney Diseases Inflammatory Bowel Disease Genetics Consortium (NIDDK IBDGC), Rivas, M. A., United Kingdom Inflammatory Bowel Disease Genetics Consortium, International Inflammatory Bowel Disease Genetics Consortium, Beaudoin, M., Gardet, A., Stevens, C., Sharma, Y., Zhang, C. K., Boucher, G., et al. (2011) · Nature Genetics · doi:10.1038/ng.952 · Cited by 771
“Strong familial aggregation has been observed in twin studies of Crohn's disease and ulcerative coliti”
BackgroundSelf-citationGene-microbiota interactions contribute to the pathogenesis of inflammatory bowel disease
Chu, H., Khosravi, A., Kusumawardhani, I. P., Kwon, A. H. K., Vasconcelos, A. C., Cunha, L. D., Mayer, A. E., Shen, Y., Wu, W.-L., Kambal, A., et al. (2016) · Science · doi:10.1126/science.aad9948 · Cited by 647
“Concordance rates of 40-50% between monozygotic twins implicate gene-environment interactions contribute to CD (7-10), albeit in ways that are poorly understood.”
BackgroundRecent Insights Into the Genetics of Inflammatory Bowel Disease
Cho, J. H., & Brant, S. R. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.02.046 · Cited by 425
Self-citationDiagnosis and classification of ulcerative colitis
Conrad, K., Roggenbuck, D., & Laass, M. W. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.01.028 · Cited by 368
Laroui, H., Ingersoll, S. A., Liu, H. C., Baker, M. T., Ayyadurai, S., Charania, M. A., Laroui, F., Yan, Y., Sitaraman, S. V., & Merlin, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032084 · Cited by 346
Trépo, E., Romeo, S., Zucman-Rossi, J., & Nahon, P. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.03.011 · Cited by 291
The influence of the gut microbiome on obesity, metabolic syndrome and gastrointestinal disease
Parekh, P. J., Balart, L. A., & Johnson, D. A. (2015) · Clinical and Translational Gastroenterology · doi:10.1038/ctg.2015.16 · Cited by 219
“mental factors, as evident by the discordance in several twin studies.(40,41) With that being said, the host genome may have”
BackgroundCheng, L., Jin, H., Qiang, Y., Wu, S., Yan, C., Han, M., Xiao, T., Yan, N., An, H., Zhou, X., et al. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.08.018 · Cited by 98
Metadata
- Authors
- Brant, S. R.
- Venue
- Inflammatory Bowel Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-01
- Volume
- 17
- Issue
- 1
- Pages
- 1-5
- ISSN
- 1078-0998 (ISSN-L)
- OpenAlex
- W2033275384
- Cited by
- 123
- References
- 2
- FWCI
- 3.19
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.